(Q51732343)

11 April 2018

title

FOXP3 and survival in urinary bladder cancer. (English)

1 reference

11 April 2018

author

Katarina Selling

7

1 reference

11 April 2018

author name string

Malin E Winerdal

1

1 reference

11 April 2018

Per Marits

2

1 reference

11 April 2018

Max Winerdal

3

1 reference

11 April 2018

Mudhar Hasan

4

1 reference

11 April 2018

Robert Rosenblatt

5

1 reference

11 April 2018

Anna Tolf

6

1 reference

11 April 2018

Amir Sherif

8

1 reference

11 April 2018

Ola Winqvist

9

1 reference

11 April 2018

publication date

18 January 2011

1 reference

11 April 2018

published in

BJU International

1 reference

11 April 2018

volume

108

1 reference

11 April 2018

issue

10

1 reference

11 April 2018

page(s)

1672-1678

1 reference

11 April 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Mechanisms of immune evasion by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

FOXP3 promoter demethylation reveals the committed Treg population in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Molecular mechanisms underlying FOXP3 induction in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

CD4 regulatory T cells in human cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Foxp3 expression in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

FOXP3 expression and overall survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Methods for categorizing a prognostic variable in a multivariable setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Cancer vaccines: moving beyond current paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Three distinct domains contribute to nuclear transport of murine Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.10020.X

10.1111/J.1464-410X.2010.10020.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018